- Home
- WXM vs CRIS Comparison
WXM vs CRIS Comparison
Compare WXM & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WXM
- CRIS
- Stock Information
- Founded
- WXM 2009
- CRIS 2000
- Country
- WXM China
- CRIS United States
- Employees
- WXM N/A
- CRIS N/A
- Industry
- WXM
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WXM
- CRIS Health Care
- Exchange
- WXM NYSE
- CRIS Nasdaq
- Market Cap
- WXM 18.9M
- CRIS 21.3M
- IPO Year
- WXM 2025
- CRIS 2000
- Fundamental
- Price
- WXM $3.75
- CRIS $1.80
- Analyst Decision
- WXM
- CRIS Strong Buy
- Analyst Count
- WXM 0
- CRIS 2
- Target Price
- WXM N/A
- CRIS $16.50
- AVG Volume (30 Days)
- WXM 159.3K
- CRIS 179.9K
- Earning Date
- WXM 01-01-0001
- CRIS 07-31-2025
- Dividend Yield
- WXM N/A
- CRIS N/A
- EPS Growth
- WXM 67.61
- CRIS N/A
- EPS
- WXM 0.18
- CRIS N/A
- Revenue
- WXM $15,524,259.00
- CRIS $11,202,000.00
- Revenue This Year
- WXM N/A
- CRIS N/A
- Revenue Next Year
- WXM N/A
- CRIS $10.67
- P/E Ratio
- WXM $21.19
- CRIS N/A
- Revenue Growth
- WXM 10.86
- CRIS 14.17
- 52 Week Low
- WXM $1.52
- CRIS $1.02
- 52 Week High
- WXM $7.99
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- WXM N/A
- CRIS 42.69
- Support Level
- WXM N/A
- CRIS $1.70
- Resistance Level
- WXM N/A
- CRIS $2.01
- Average True Range (ATR)
- WXM 0.00
- CRIS 0.21
- MACD
- WXM 0.00
- CRIS -0.03
- Stochastic Oscillator
- WXM 0.00
- CRIS 38.78
About WXM WF INTERNATIONAL LIMITED
WF International Ltd is engaged in the provision of supply, installation, fitting-out and maintenance services for HVAC system and floor heating systems. It provides the supply, installation and fitting-out services for HVAC systems for large-scaled commercial projects consisting of offices, hotels, manufactures, airports and hospitals, such as the International Finance Square HVAC projects across China, Chengdu Vanke Charm City, Chengdu Raffles Plaza, Chengdu Yinshi Plaza, Chengdu Metro No. Ten Line, and Panzhihua Jinhai Hotel.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.